CitriniPocalypse, Dot Com Lore, Gene-Edited Polo Horses | Alap Shah, Will Brown, Michelle Lee, Mike Annunziata - TBPN Recap

Podcast: TBPN

Published: 2026-02-23

Duration: 3 hr 18 min

Guests: Alap Shah, Will Brown, Michelle Lee, Mike Annunziata

Summary

The episode explores the impact of speculative market scenarios, the role of AI in financial and tech sectors, and innovations in biotechnology and venture capital. It features discussions on AI-driven market disruptions, open-source model advancements, and gene-edited polo horses.

What Happened

A speculative post by Citrini caused a massive sell-off in the markets, labeled the 'CitriniPocalypse,' highlighting the potential impact of AI on market stability. This scenario, despite being framed as fan fiction, led to significant declines in stocks like DoorDash and American Express, raising concerns about the future of consumer demand and employment due to AI's influence.

John Loeber critiqued Citrini's scenario, arguing for the durability of institutional inertia and suggesting that the demand for labor in the software sector remains infinite. Loeber emphasized the importance of reindustrialization and infrastructure work as solutions to AI-induced labor displacement, challenging the doomsday predictions of AI-driven economic collapse.

Alap Shah, co-founder of Sentieo, discussed the transformative effects of AI on white-collar employment, noting a decline in information sector jobs since 2022. He highlighted the need for proactive measures to mitigate AI's disruptive potential as corporate adoption accelerates, potentially reshaping the labor market.

Will Brown introduced Prime Intellect's new training platform for reinforcement learning, which simplifies the use of open-source models by focusing on environment design and task specification. This platform has been positively received, showcasing the potential for customization and state-of-the-art performance in specialized tasks.

Michelle Lee, CEO of Medra, shared her company's vision of using physical AI scientists to automate laboratory experiments and accelerate drug discovery. With a recent $52 million Series A funding, Medra aims to build one of the largest autonomous labs in the U.S., partnering with pharmaceutical companies to revolutionize drug development.

Mike Annunziata, managing partner at Also Capital, discussed his venture capital approach, emphasizing the importance of investing in founders with a pragmatic vision and the ability to attract top talent. He announced the launch of Also Capital's second fund, highlighting the significance of having fun while achieving success in the venture capital landscape.

The episode also touched on the historical context of the Dot Com Boom, comparing past predictions with present-day technological advancements. Discussions included the ongoing evolution of AI and its potential to reshape industries beyond traditional software solutions, emphasizing both challenges and opportunities in the tech landscape.

Key Insights

Key Questions Answered

What was the CitriniPocalypse market impact?

The CitriniPocalypse refers to a massive market sell-off attributed to a speculative post by Citrini, which led to declines in stocks like DoorDash and American Express as investors reacted to potential AI-driven economic disruptions.

How is Medra using AI in drug discovery?

Medra is developing physical AI scientists to automate laboratory experiments, aiming to accelerate drug discovery. They recently secured $52 million in Series A funding to build a large autonomous lab in the U.S.

What is Prime Intellect's new platform?

Prime Intellect released a training platform that simplifies reinforcement learning on open-source models, allowing users to focus on environment design and task specification for effective model training.